The Scientist

» drug development and immunology

Most Recent

image: Treating Toxoplasmosis

Treating Toxoplasmosis

By | September 25, 2015

While one company hikes the price of an old drug to treat the parasitic infection, academic researchers report that an approved blood pressure medication could be just what the doctor ordered.

4 Comments

image: Drug Pricing Incites Outrage

Drug Pricing Incites Outrage

By | September 22, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Dengue’s Downfall?

Dengue’s Downfall?

By | September 15, 2015

Researchers characterize a protein that could be key to the virus’s virulence—and to developing a vaccine against the mosquito-borne disease.

0 Comments

image: Immune Cells Can Deliver Deadly Packages

Immune Cells Can Deliver Deadly Packages

By | September 8, 2015

Much of the CD4+ T-cell death that occurs during HIV infection may be caused by direct delivery of the virus from neighboring cells, a study shows.

0 Comments

image: TS Picks: September 8, 2015

TS Picks: September 8, 2015

By | September 8, 2015

Pharma edition

0 Comments

image: Body, Heal Thyself

Body, Heal Thyself

By | September 1, 2015

Reviving a decades-old hypothesis of autoimmunity

8 Comments

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

3 Comments

image: Hearing Help

Hearing Help

By | September 1, 2015

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.  

2 Comments

image: Hope for Universal Flu Vax?

Hope for Universal Flu Vax?

By | August 26, 2015

Two studies point to the possibility that a single vaccine could protect against every strain of flu virus.

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

Popular Now

  1. NYU Halts Studies, Suspends Investigator
    The Nutshell NYU Halts Studies, Suspends Investigator

    Experiments conducted at the New York University School of Medicine violated several research standards, according to US Food and Drug Administration investigators.

  2. Exercise-Induced Muscle Factor Promotes Memory
  3. The Meaning of Pupil Dilation
    Daily News The Meaning of Pupil Dilation

    Scientists are using pupil measurements to study a wide range of psychological processes and to get a glimpse into the mind.

  4. Brexit’s Effects on Science
Biosearch Technologies